Trade ZLAB stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Zai Lab Limited American Depositary Shares (ZLAB) is trading at US$24.17, down 3.63% today as of Sep 10, 16:00 EDT. The company has a market capitalisation of US$2.92B. Over the past 52 weeks, ZLAB has traded between US$15.96 and US$34.72. On Syfe you can trade ZLAB with $0 commission and add it to your watchlist.
| Previous close | US$25.08 |
|---|---|
| Market cap | US$2.92B |
| 52-week range | US$15.96 – US$34.72 |
| Volume | 1.61M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Zai Lab Limited American Depositary Shares
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. Its products include Zejula, Optune, Qinlock, and Nuzyra. The company was founded by Samantha Ying Du and Marietta Wu in April 2014 and is headquartered in Shanghai, China.
Year: 2017
Zai Lab Shares Rise After Q2 Beat
Aug 6, 1:39 PM · MT Newswires
-- Earnings Flash (ZLAB) Zai Lab Limited Reports Q2 Revenue $106.3M, vs. FactSet Est of $103.9M
Aug 6, 10:36 AM · MT Newswires
-- Earnings Flash (ZLAB) Zai Lab Limited Reports Q2 Loss of $0.46 per ADS, vs. FactSet Est of $-0.68
Aug 6, 10:36 AM · MT Newswires
Zai Lab Receives FDA Orphan Drug Designation for Zocilurtatug Pelitecan in Neuroendocrine Carcinomas
Aug 3, 11:43 AM · MT Newswires
Zai Lab Insider Sold Shares Worth $428,545, According to a Recent SEC Filing
Jun 29, 8:24 PM · MT Newswires
Stay on top of ZLAB
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
